Suppr超能文献

纤维蛋白胶注射:难治性括约肌切开术后和乳头切开术后出血的抢救治疗。

Fibrin glue injection: Rescue treatment for refractory post-sphincterotomy and post-papillectomy bleedings.

机构信息

Digestive Endoscopy Unit, Foundation Policlinico Agostino Gemelli IRCCS, Rome, Italy.

Centre for Endoscopic Research Therapeutics and Training (CERTT), Catholic University of the Sacred Heart, Rome, Italy.

出版信息

Dig Endosc. 2021 Jul;33(5):815-821. doi: 10.1111/den.13857. Epub 2020 Nov 27.

Abstract

OBJECTIVES

Endoscopic sphincterotomy (ES) and papillectomy (EP) are associated with a non-negligible risk of post-procedural bleeding. Despite first-line endoscopic hemostasis being achieved by several methods, patients may experience bleeding persistence or recurrence. In such cases, fibrin glue (FG) injection may be used as a rescue therapy before more invasive approaches. The aim of this study was to evaluate the efficacy and safety of endoscopic FG injection to treat refractory post-ES and post-EP bleeding.

METHODS

Data were collected retrospectively from patients with refractory immediate or delayed bleeding following ES or EP, between October 2007 and November 2019, at a single institution. Clinical success was defined as bleeding control after FG injection.

RESULTS

Overall, 70 patients were included. Clinical success was reached in 64 (91.4%) patients after one session of FG injection. Of six (8.6%) patients in whom the treatment failed, one required subsequent insertion of a fully covered self-expanding metal stent (FC-SEMS) due to immediate massive bleeding, while five experienced bleeding recurrence. Such events were managed with an additional session of FG injection that failed in two cases. Therefore, one patient underwent FC-SEMS plus selective embolization, whereas the other underwent diagnostic arteriography. No severe periprocedural complications occurred. Two cases of intrabiliary glue migration were treated by endoscopic removal with a retrieval basket.

CONCLUSIONS

Rescue therapy with endoscopic FG injection appears to be effective and safe to treat refractory post-ES and post-EP bleeding. Further studies are required to confirm these preliminary data.

摘要

目的

内镜下括约肌切开术(ES)和乳头切开术(EP)与相当大的术后出血风险相关。尽管有几种方法可以实现一线内镜止血,但患者可能会出现出血持续或复发。在这种情况下,纤维蛋白胶(FG)注射可作为更具侵入性方法之前的抢救治疗。本研究旨在评估内镜 FG 注射治疗难治性 ES 和 EP 术后出血的疗效和安全性。

方法

数据是从 2007 年 10 月至 2019 年 11 月在一家机构接受 ES 或 EP 后出现即时或延迟出血的难治性患者中回顾性收集的。临床成功定义为 FG 注射后出血得到控制。

结果

总体而言,共纳入 70 例患者。64 例(91.4%)患者经一次 FG 注射治疗后达到临床成功。6 例(8.6%)治疗失败的患者中,1 例因即刻大出血需要随后插入全覆膜自膨式金属支架(FC-SEMS),5 例患者发生出血复发。对这两例患者采用额外的 FG 注射治疗,但均未成功。因此,1 例患者行 FC-SEMS 加选择性栓塞治疗,另 1 例患者行诊断性动脉造影。无严重围手术期并发症发生。2 例胆管内胶迁移患者采用取物篮进行内镜下取出治疗。

结论

内镜 FG 注射抢救治疗难治性 ES 和 EP 术后出血似乎是有效和安全的。需要进一步的研究来证实这些初步数据。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验